Literature DB >> 1982184

Clinical pharmacology and Leonhard's classification of endogenous psychoses.

T A Ban1.   

Abstract

Introduction of therapeutically effective psychotropic drugs focused attention on the heterogeneity of psychiatric populations within the traditional diagnostic categories of psychiatric disorders. Recognition that valid diagnostic concepts are essential for progress in the biology and pharmacotherapy of psychiatric disorders resulted in a revival of interest in psychiatric nosology with a special emphasis on Leonhard's classification of 'endogenous psychoses'. Of particular importance for psychopharmacology in Leonhard's system is the recognition of two distinctive populations within the schizophrenic disorders, i.e., 'unsystematic schizophrenias' and 'systematic schizophrenias'; three distinctive populations within the bipolar disorders, i.e., 'manic-depressive illness,' 'cycloid psychoses' and 'unsystematic schizophrenias'; and two distinctive populations within depressive disorders, i.e., 'unipolar depression' and 'bipolar depression'. In this paper supporting data for Leonhard's classification of 'endogenous psychoses' are presented.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1982184     DOI: 10.1159/000284677

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  2 in total

1.  Fifty years chlorpromazine: a historical perspective.

Authors:  Thomas A Ban
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

Review 2.  Wernicke-Kleist-Leonhard phenotypes 
of endogenous psychoses: a review of their validity
.

Authors:  Jack R Foucher; Micha Gawlik; Julian N Roth; Clément de Crespin de Billy; Ludovic C Jeanjean; Alexandre Obrecht; Olivier Mainberger; Julie M E Clauss; Julien Elowe; Sébastien Weibel; Benoit Schorr; Marcelo Cetkovich; Carlos Morra; Federico Rebok; Thomas A Ban; Barbara Bollmann; Mathilde M Roser; Markus S Hanke; Burkhard E Jabs; Ernst J Franzek; Fabrice Berna; Bruno Pfuhlmann
Journal:  Dialogues Clin Neurosci       Date:  2020-03       Impact factor: 5.986

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.